Global Biopharmaceutical Market Size By Product Type (Monoclonal Antibodies, Recombinant Growth Factors), By Service (Laboratory Testing, Custom Testing / Customer Proprietary Testing), By Raw Material Type (Formulation Excipients, Active Pharmaceutical Ingredients (API)), By Application (Oncology, Inflammatory and Infectious Diseases), By Geographic Scope And Forecast

Biopharmaceutical Market Size And Forecast

Biopharmaceutical Market size was valued at USD 370 Billion in 2022 and is projected to reach USD 865.93 Billion by 2030, growing at a CAGR of 11.8% from 2023 to 2030.

The market’s expansion is being driven by factors such as the growing acceptance of biopharmaceuticals, their enormous market demand, and their capacity to treat diseases that were previously untreatable. The Global Biopharmaceutical Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Biopharmaceutical Market Definition

The business that designs, manufactures, and sells biopharmaceutical products is referred to as the biopharmaceutical market. Medical drugs that are derived from biological sources, like living organisms or their components, are known as biopharmaceuticals. They are used to diagnose, treat, and prevent diseases. This market remembers organizations that concentration for innovative work of biopharmaceuticals, as well as those that assembling, disperse, and market these items to medical care suppliers and patients. The demand for personalized medicine and advancements in biotechnology are expected to continue driving growth in the biopharmaceutical market, which is an important part of the global pharmaceutical industry.

Global Biopharmaceutical Market Overview

The biopharmaceutical industry was significantly affected by the COVID-19 pandemic. Most biopharmaceutical organizations strived broadly to foster antibodies against the SARS-CoV-2 infection. For instance, the Department of Biotechnology implemented Mission COVID Suraksha, which the Indian government announced in April 2021 to accelerate the development and production of indigenous COVID vaccines. Between July and August of 2021, Covaxin’s production capacity increased from 1 crore vaccine doses in April 2021 to 6-7 crore vaccine doses per month. In addition, by September 2021, it will have reached nearly ten crore doses per month. On the other hand, in June 2022, Pfizer announced that it would invest 120 million US dollars in US manufacturing at its Kalamazoo (Michigan) facility. This would make it possible to produce COVID-19 oral treatment, PAXLOVID (nirmatrelvir [PF-07321332] tablets, and ritonavir tablets in the United States.

The investment is yet another significant step in Pfizer’s effort to increase the amount of vital biopharmaceutical manufacturing in the United States. This will increase Pfizer’s capacity to manufacture and supply medications and treatments to patients in the United States and around the world. Additionally, in August 2021, the Public Authority of Canada declared a concurrence with driving COVID­-19 immunization engineer Moderna, Inc. to construct an mRNA immunization office in Canada. Moderna’s plans to construct a facility in Canada to manufacture mRNA vaccines were in line with the objectives of the recently announced biomanufacturing and life science strategy. The move will boost the biomanufacturing and life sciences industry’s entire value chain, from talent acquisition and retention to increased clinical trial capacity, as well as Canada’s overall industrial competence. The expanded revenue in assembling Coronavirus antibodies has altogether added to the development of the biopharmaceutical market during the Coronavirus pandemic.

The market’s expansion is being driven by factors such as the growing acceptance of biopharmaceuticals, their enormous market demand, and their capacity to treat diseases that were previously untreatable. Five medications for the treatment of Alzheimer’s disease were approved by the US Food and Drug Administration (FDA) in accordance with the Alzheimer’s Association 2021 report. They are rivastigmine, galantamine, donepezil, memantine, and memantine, joined with donepezil. The same source says that people over the age of 65 are most likely to get Alzheimer’s disease. It is considered late-beginning Alzheimer’s. Nearly 5.3 percent of Americans aged 65 to 74, 13.8 percent of Americans aged 75 to 84, and 34.6% of Americans aged 85 and older suffer from Alzheimer’s disease. Additionally, by 2050, 13.5 million Americans over the age of 65 will have Alzheimer’s disease, up from 6.2 million in 2021. Such a higher sickness commonness will reinforce the interest in the Programming interfaces among the patient populace throughout the next few years.

Global Biopharmaceutical Market Segmentation Analysis

The Global Biopharmaceutical Market is Segmented on the basis of Product Type, Service, Raw Material Type, Application, And Geography.

Biopharmaceutical Market, By Product Type

• Monoclonal Antibodies
• Recombinant Growth Factors
• Purified Proteins
• Recombinant Proteins
• Recombinant Hormone
• Vaccines
• Synthetic Immunomodulators
• Other

Based on Product Type, the market is segmented into Monoclonal Antibodies, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormone, Vaccines, Synthetic Immunomodulators, and Other.

Biopharmaceutical Market, By Service

• Laboratory Testing
• Custom Testing / Customer Proprietary Testing
• Compendial and Multi Compendial Laboratory Testing

Based on Service, the market is segmented into Laboratory Testing, Custom Testing / Customer Proprietary Testing, and Compendial and Multi Compendial Laboratory Testing.

Biopharmaceutical Market, By Raw Material Type

• Formulation Excipients
• Active Pharmaceutical Ingredients (API)
• Compendial Methods (USP / EP / JP)
• Based Vendor Qualification Program Support

Based on Raw Material Type, the market is segmented into Formulation Excipients, Active Pharmaceutical Ingredients (API), Compendial Methods (USP / EP / JP), and Based Vendor Qualification Program Support.

Biopharmaceutical Market, By Application

• Oncology
• Inflammatory and Infectious Diseases
• Autoimmune Disorders
• Metabolic Disorders
• Hormonal Disorders
• Cardiovascular Diseases
• Neurological Diseases
• Other

Based on Application, the market is segmented into Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Cardiovascular Diseases, Neurological Diseases, And Other.

Biopharmaceutical Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the world

On the basis of Geography, the Global Biopharmaceutical Market is classified into North America, Europe, Asia Pacific, Latin America, And the Rest of the world. A high level of population awareness and rising rates of chronic diseases like arthritis, rheumatoid arthritis, and cancer contribute to North America’s dominance. The global biopharmaceutical market is also bolstered by developments in healthcare infrastructure, rising government spending on healthcare policies, and the presence of significant players in North America. On the other hand, the Asia-Pacific region is anticipated to achieve noteworthy results in the global biopharmaceutical market. Increased demand for biopharmaceuticals is a result of substantial investment, significant government involvement in the healthcare industry, and significant economic development in the developing world.

Key Players

The “Global Biopharmaceutical Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott, Amgen Inc, Biogen Inc, Eli Lilly and Company, Hoffmann-La Roche AG, Johnson & Johnson Services, Inc, Merck Sharp & Dohme Corp, Novo Nordisk A/S, Pfizer Inc., Sanofi.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• July 2022Amgen bought ChemoCentryx, Inc., which treats cancer, autoimmune diseases, and inflammatory disorders, for approximately USD 3.7 billion, or 52 cents per share in cash.
• May 2022The East Syracuse, New York, manufacturing facility of Bristol Myers Squibb was purchased by LOTTE. For the purpose of LOTTE’s brand-new biologics contract development and manufacturing organization (CDMO) business in the United States, the East Syracuse location will function as the LOTTE Center for North America Operations.
• January 2022Amgen and Generate Biomedicines worked together to discover and develop protein therapies for five clinical targets in a variety of therapeutic areas and modalities.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Biopharmaceutical Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in Global Biopharmaceutical Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .